A detailed history of Truvestments Capital LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 437 shares of AUPH stock, worth $3,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
437
Holding current value
$3,500
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.32 - $7.33 $2,324 - $3,203
437 New
437 $3,000
Q1 2023

May 12, 2023

BUY
$5.94 - $11.27 $2,892 - $5,488
487 Added 243.5%
687 $7,000
Q2 2022

Aug 09, 2022

BUY
$8.95 - $12.8 $1,789 - $2,560
200 New
200 $2,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.